Development of Dual Functional Nucleic Acid Delivery Nanosystem for DNA Induced Silencing of Bcl-2 Oncogene

Somayeh Karimi1, Mohamad Hassan Fouani2, Ahmad Moshaii1

  • 1Department of Physics, Tarbiat Modares University, Tehran, Iran.

Abstract

Insights

Gold nanoparticles functionalized with DNA inhibitors targeting Bcl-2 show size-dependent cellular uptake in cancer cells. The largest nanoparticles (~42 nm) exhibit enhanced internalization and potent anticancer effects via gene silencing and photothermal therapy.

Area of Science:

  • Nanotechnology
  • Biomedical Engineering
  • Cancer Research

Background:

  • Gene silencing is a promising cancer treatment strategy.
  • Functionalized nanoparticles offer targeted drug delivery.
  • Bcl-2 gene plays a crucial role in cancer cell survival.

Purpose of the Study:

  • Investigate cellular uptake and cytotoxicity of anti-Bcl-2 DNA inhibitor-conjugated gold nanoparticles (Au-NPs).
  • Evaluate the effect of Au-NP size on cellular internalization and anticancer efficacy.
  • Explore the potential of these nanoparticles as dual-functional anticancer agents.

Main Methods:

  • Synthesis and characterization of three sizes of Au-NPs (~14, ~26, ~42 nm).
  • Functionalization of Au-NPs with Bcl-2 targeted DNA inhibitor (DNAi).
  • Assessment of cellular uptake (atomic absorption spectroscopy, light microscopy) and cytotoxicity (MTT assay, flow cytometry, RT-PCR).
  • Evaluation of photothermal properties and temperature elevation effects.

Main Results:

  • Cellular uptake of DNAi-conjugated Au-NPs is size-dependent, with ~42 nm particles showing the highest internalization.
  • DNAi-conjugated Au-NPs induce apoptosis by silencing the Bcl-2 gene.
  • ~42 nm DNAi-conjugated Au-NPs exhibit significant photothermal conversion efficiency, capable of increasing temperature by ~10°C for enhanced cytotoxicity.

Conclusions:

  • DNAi-conjugated 42 nm Au-NPs demonstrate high cell internalization and potent cytotoxic effects.
  • These nanoparticles possess remarkable photothermal properties, enabling dual-mode cancer therapy.
  • The developed Au-NPs represent promising dual-functional anticancer nanosystems.

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K